Suppr超能文献

伊立替康所致腹泻的防护干预措施的效果:系统评价和荟萃分析。

Efficiency of Protective Interventions on Irinotecan-Induced Diarrhea: A Systematic Review and Meta-Analysis.

机构信息

The Affiliated Hospital of Southwest Medical University, Luzhou, China.

Zunyi Medical University, Zunyi, China.

出版信息

Integr Cancer Ther. 2024 Jan-Dec;23:15347354241242110. doi: 10.1177/15347354241242110.

Abstract

BACKGROUND

Irinotecan is widely used in the treatment of various solid tumors, but the adverse effects from it, especially diarrhea, limit its use. Several clinical trials of prophylactic treatment of irinotecan-induced diarrhea (IID) have been ongoing, and some of the data are controversial. This encouraged us to conduct a meta-analysis of the effects of interventions on preventing IID.

METHOD

This systematic review was conducted based on the PRISMA statement. We performed literature searches from PubMed, Web of Science, Embase, and Cochrane Library. The number registered in PROSPERO is CRD42022368633. After searching 1034 articles in the database and references, 8 studies were included in this meta-analysis.

RESULT

The RR of high-grade diarrhea and all-grade diarrhea were 0.31 ( = 51%, 95% CI: 0.14-0.69;  = .004) and .76 ( = 65%, 95% CI: 0.62-0.93;  < .008) respectively, thus the use of intervention measures for preventing IID is effective, and the risk reduction of high-grade diarrhea was more significant. Subgroup analysis revealed that the monotherapy group (RR: 0.48, 95% CI: 0.21-1.13,  = 0%) and combination therapy group (RR: 0.14, 95% CI: 0.06-0.32,  = 0%) in the risk of high-grade diarrhea had no significant heterogeneity within the groups, and traditional herbal medicines (Kampo medicine Hangeshashin-to, PHY906 and hot ironing with Moxa Salt Packet on Tianshu and Shangjuxu) were effective preventive measures (RR:0.20, 95% CI: 0.07-0.60,  = 0%). The Jadad scores for traditional herbal medicines studies were 3, and the follow-up duration was only 2 to 6 weeks.

CONCLUSION

This systematic review and meta-analysis suggest that preventive treatments significantly reduced the risk of high-grade and all-grade diarrhea, confirming the efficacy in the incidence and severity of IID, among which traditional herbal medicines (baicalin-containing) provided a protective effect in reducing the severity of IID. However, the traditional herbal medicines studies were of low quality. Combined irinotecan therapy can obtain better preventive effects than monotherapy of IID. These would be helpful for the prevention of IID in clinical practice.

摘要

背景

伊立替康广泛用于治疗各种实体瘤,但因其引起的不良反应,尤其是腹泻,限制了其应用。目前正在进行多项伊立替康诱导的腹泻(IID)预防性治疗的临床试验,部分数据存在争议。这促使我们对干预措施预防 IID 的效果进行荟萃分析。

方法

本系统评价按照 PRISMA 声明进行。我们从 PubMed、Web of Science、Embase 和 Cochrane Library 进行文献检索。PROSPERO 注册号为 CRD42022368633。在数据库和参考文献中搜索了 1034 篇文章后,有 8 项研究纳入本荟萃分析。

结果

高级别腹泻和全级别腹泻的 RR 分别为 0.31( = 51%,95%CI:0.14-0.69; = 0.004)和 0.76( = 65%,95%CI:0.62-0.93; < 0.008),表明预防 IID 的干预措施有效,高级别腹泻的风险降低更为显著。亚组分析显示,在高级别腹泻风险方面,单药治疗组(RR:0.48,95%CI:0.21-1.13, = 0%)和联合治疗组(RR:0.14,95%CI:0.06-0.32, = 0%)组内无明显异质性,传统草药(汉方方剂黄芩汤、PHY906 和铁灸天枢和上巨虚用艾盐包)是有效的预防措施(RR:0.20,95%CI:0.07-0.60, = 0%)。传统草药研究的 Jadad 评分均为 3 分,随访时间仅为 2 至 6 周。

结论

本系统评价和荟萃分析表明,预防治疗可显著降低高级别和全级别腹泻的风险,证实了其在 IID 发生率和严重程度方面的疗效,其中(含黄芩苷的)传统草药在降低 IID 严重程度方面提供了保护作用。然而,传统草药研究的质量较低。联合伊立替康治疗可获得比 IID 单药治疗更好的预防效果。这些结果有助于在临床实践中预防 IID。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc7/10993684/8379f3cbead7/10.1177_15347354241242110-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验